Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of Cobimetinib Alone or with Atezolizumab in Advanced Solid Tumors
jRCT2080223552Phase 1Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jun 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of cobimetinib and atezolizumab in Nonhematologic neoplasms (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Started Jun 2017; status: completed.
02
Drugs
cobimetinibatezolizumab
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080223552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223552.